chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two hours after receiving the vaccine I started having heart palpitations and SOB that lasted until 09:00PM that night. On Friday, I experienced the same thing. Saturday, it started earlier in the day and it lasted until I went to bed at 11:00PM. On Sunday morning, when I woke, I still had the palpitations and the they were worse. All of the testing that they performed came back normal. They ruled out a heart attack and assumed I was having a panic attack. I went to see my PCP on Friday and everything checked out fine. My cousin had the same exact symptoms and she was told the same thing. I have not had any more palpitations since the last time and my breathing is good too.
got the booster dose from the expired vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got the booster dose from the expired vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (got the booster dose from the expired vial). On 19-Nov-2021, EXPIRED PRODUCT ADMINISTERED (got the booster dose from the expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   N concomitant medications was reported. No treatment drug details was reported.
Symptoms were sever dizziness on Saturday after swimming and then again before bed. Since that time, dizziness and nausea comes in waves throughout the day, usually lasting for about 10 min, relieved by stepping into fresh air. It is most prevalent in the morning and evening.
I experienced after my vaccine, I had little swelling, redness and a little tender. I also had a slight headache that came and went. My symptoms cleared pretty fast within a few days.
Rash under left eye, mild numbness and swelling in both hands, Slight pain in Right wrist, Soreness in legs and Left achilles tendon pain starting approximately week of November 13,  and worse week of December 11 after 3 JE vaccine did not correlate events with vaccine until after 3rd dose of JE. Rash under left eye gettim.  1/8/07 Received medical records from PCP which reveal: Patient seen 12/13/06 with c/o rash on left side of face s/p 2nd JE vax.  Also shortly after 3rd JE vax, had joint aches/pains.  Patient was planning to travel to India 12/06.  Exam revealed small patch of tiny slightly reddened vesicular lesions on left side of face just lateral of the lateral canthus of the eye.  All joints had full ROM.  NSAIDs were only treatment recommended. Dx: probable reaction to innoculations resulting in phenomena similar to a fixed drug reaction & serum sickness, with both resolving.
I have had diarrhea consistently since March 10th, at least 5 times a day. I've also been very nauseous with little appetite.
9/29/08: Pt reports noticed at 8pm that she had some soreness and redness to her R arm where pneumonia shot was given. 10/1/08: 1150am Pt reports that today she has more redness, soreness, warmth and swelling to inner R arm area above elbow.
The side effects began the night following my vaccine and lasted the entire next day. It began with fatigue/brain fog, then chills and soreness at the injection site. Once the chills began I was very ill with a fever (100-101), severe aches and pains in my body from head to toe, and experienced  occasional shooting pains. Once the fever went away about 30 hours after my vaccine, I still felt pain and heaviness in my body and had a bad headache. The next day (day 3) was much better- I had no fever but still felt some brain fog, drowsiness, and slight muscle soreness (but no pain).   Two weeks after my vaccine (4/20/21)  I had a very similar experience but am not certain it was related to the vaccine. I developed chills, fatigue, and a headache for the majority of the day. In the evening, it progressed to muscle/joint pain, a severe headache, extreme fatigue, and a 100 degree fever. The next day (today 4/21), the fever has subsided and I feel slightly fatigued. Though I am not sure this was related to the vaccine, it mirrored my initial reaction to the vaccine two weeks prior. It is very unusual for me to get a fever in the 100 degree range and typically only happens every two years or so.
rash began morning following vax;started on arms & spread to face;t101 (not given prophylactic APAP);rash lasted 2 days w/welts, blotches;resolved;recurred on 3rd day;placed on DPH;MD felt rash r/t Hep B vax;
hypertensive crisis; mental fog; I had systemic reaction with numbness; tingling; extreme nausea; headache; thirst; palpitations; changes to color of extremities; cold/heat intolerance; diuresis; inability to eat; inability to eat or sleep; This is a spontaneous report from a contactable Nurse (patient). A 49-year-old female (not pregnant) patient received BNT162B2 (lot number: ek9231) second dose on 06Jan2021 on left arm at single dose for covid-19 immunization. Medical history included hypothyroidism and allergies to penicillin. Concomitant medications in two weeks included levothyroxine sodium (SYNTHROID), liothyronine, magnesium carbonate (MAG 2), trimebutine maleate (MOTRI), zinc, curcuma longa (CURCUMA). The patient previously took BNT162B2 (lot number: ek5730) first dose on 17Dec2020 10:00 AM (age of vaccination was 49-year-old) on left arm for covid-19 immunization. Facility type vaccine was Hospital. No other vaccine in four weeks. On 10Feb2021 07:00 (also reported as 08Feb2021), approximately one month after 2nd vaccine, patient received a steroid epidural with contrast and a day after she had systemic reaction with numbness, tingling, extreme nausea, headache, thirst, palpitations, hypertensive crisis, changes to color of extremities, cold/heat intolerance, extreme thirst, mental fog, diuresis, inability to eat or sleep. Not sure if related to vaccine. No COVID prior vaccination. COVID tested post vaccination (Nasal Swab, PCR) on 17Feb2021 and result was Negative. The outcome of the event was recovering. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization]. Hospitalization for 2 days. Patient received symptomatic management as treatment.; Sender's Comments: It is unclear what was the indication for the mentioned 'steroid epidural with contrast ' performed one month after the second dose of BNT162B2. The reported systemic reaction with numbness, tingling, extreme nausea, headache, thirst, palpitations, hypertensive crisis, changes to color of extremities, cold/heat intolerance, extreme thirst, mental fog, diuresis, inability to eat or sleep seems attributable to the reported procedure, or the unspecified indication for the procedure, rather than BNT162B2 vaccine.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
A report was received from a health care professional on 10/17/01 regarding a 4 year old male patient who experienced severe cellulitis on 10/16/01 after receiving Fluvirin vaccine (batch E05211KA) on 10/15/01. Concomitant medications included Ranitidine hydrochloride, Salbutamol and Cromoglicate sodium. The patient had 2 previous administrations of influenza vaccine in 2000 and 1999 without any adverse reaction. On 10/16//01, the patient's parent reported a severe cellulitis on their son's arm, located below the deltoid and above the elbow, at the site of the injection. The patient was seen by a physician on 10/17/01 when the cellulitis area was determined to be approximately 11.5cm by 12.5cm in size. The event was considered to be medically significant. The physician prescribed oral Cephalexin antibiotic to treat the cellulitis. The event was still ongoing at the time of reporting. The reporter has assessed the relationship of study medication to the event as probable. (OMIC)
Swelling and redness of R thigh. R thigh cellulitis, treated with Augmentin and Rocephin 750mg.
Fever 103.8, headache, myalgia followed by resolution of fever and arthralgia in knees.
blurred vision; Was not feeling well; stayed in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Was not feeling well), BEDRIDDEN (stayed in bed all day) and VISION BLURRED (blurred vision) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 08-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, the patient experienced MALAISE (Was not feeling well) and BEDRIDDEN (stayed in bed all day). On 10-May-2021, the patient experienced VISION BLURRED (blurred vision). At the time of the report, MALAISE (Was not feeling well) and BEDRIDDEN (stayed in bed all day) outcome was unknown and VISION BLURRED (blurred vision) had not resolved. Not Provided          No treatment medication specified.  Action taken with mRNA-1273 in response to events was not applicable.
No additional AE reported; GARDASIL 9 administered to patient after experiencing temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided.  On 23-JUL-2020, the patient was vaccinated with improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (0.5 ml, lot# reported as 163741, which was not valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), expiration date 16-FEB-2022; route and strength were not provided) for prophylaxis. The temperature excursion included 8.83 degree Celsius for 20 hours. There was no previously temperature excursion. There was a data logger involved. No additional adverse events were reported.
After administration of single dose intramuscular inactivated influenza vaccine, woke up two days later with myalgia and low back pain, weakness, nausea, chills, mild pharyngitis.
This spontaneous report was received from physician refers to a 13 year old patient of unknown age and gender. The patient's pertinent medical history, drug reaction or allergies and concomitant medication were not reported. It was reported that, the patient was supposed to be vaccinated with a  dose of GARDASIL 9 and a dose of VAQTA (lot #, expiry date, dose, strength, vaccination site, route not provided). However, the nurse grabbed wrong tray of vaccines and the patient was inadvertently administered with a dose of (Oka-Merck) PROQUAD and KINRIX (lot #, expiry date, dose, strength, dose number, vaccination site, route not provided). No adverse effects were reported. Product quality complaint (PQC) was not involved. No additional information was provided. This is one of two reports received from the same reporter. Additional information has been requested.
Persistent crying 3 hrs p/inject w/large amount swelling in inject site; dec activity; couldn't be consoled for 3-5 hrs p/crying began; Mom states did not take to MD;
Pt has history of metabolic disease, MELAS, in which she develops acute flares with headaches, vomiting, seizures, scotomas, and strokes in reaction to specific stressors. Received Pfizer COVID vaccine on 1/21/22. Developed fatigue and decreased oral intake on 1/28, then vision loss and scotomas on  1/30, which she describes as "sparkles" in her vision. No seizures. Because of persistence of symptoms for 3 days without improvement, family brought her to the emergency room for evaluation, and she was admitted to rule out strokes and acute MELAS flare. Symptoms improved with supportive IVF, medications for acute metabolic crisis (arginine, carnitine), and OTC NSAIDs. Discharge date from hospital currently pending, but anticipated 2/3/22. OF NOTE, family reported that after receiving her 2nd dose COVID PFizer vaccine on 6/6/21, pt developed  slurred speech and HAs approximately around 6/17. MRI brain performed on 6/24 demonstrated multiple subacute infarcts consistent with acute MELAS flare, in addition to interval progression of cerebral brain loss related to chronic condition.
Information has been received from a registered nurse (RN) concerning a female who in July 2007, was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL vaccine (yeast) and on 02-SEP-2008 was vaccinated intramuscularly with the second 0.5 ml dose of GARDASIL vaccine (yeast). No problems reported. No product quality complaint was involved. Additional information has been requested.
Hx of recent hospitalization for cellulitis, dc'd home with IV antibiotic therapy; tested positive for COVID while in the hospital; presented to ED with severe hypoxia; respiratory failure with intubation; AFib; COVID pneumonia; pt passed away in the hospital
I found out that I was exposed to COVID-19. I started to have a sore throat that progressed to nasal congestion, and body aches within a couple days. I started to take over the counter Tylenol Cold and Flu medication which helped reduce the symptoms. Two days later I took a COVID-19 test that came back positive on 5/4/22.
1. 11 days post vaccination - experienced post menopausal bleeding / (28 months post menopause)  2.  2 days post vaccination - mild left facial pain and tick, appeared to subside within days.  18 weeks post vaccination - experienced sudden sensorineural hearing loss in right ear, tinnitus and headache pressure/pain in forehead with mild left facial twitching.
I had a flare up of pityriasis rosea within a week of the booster. I could not find a herald patch and this time it was itchy. Previous time I had pityriasis rosea was 2018 and wasn?t itchy and had a herald patch.  Unknown reasons for that past flare up that I could say brought on the 2021 one. Did not have unusual reactions to the first two shots.  Lasted for about a month and half before it disappeared entirely. It spanned all over the torso from shoulders to elbows and to knees. Did not go up past neck, knees or elbows.
Pt was given ZOSTAVAX (R) zoster vaccine live on 7/24/17. The next day, pt complained of redness and swelling. Pt went to ER and her PCP, her PCP confirmed that vaccine was given properly and she was experiencing an injection site reaction.
This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling, injection site warmth and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site warmth and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: The case was reported by medical assistant via click to chat. The age at vaccination was not reported. The health care professional reported that the patient received vaccine subcutaneously, which led to inappropriate route of vaccination. The health care professional might have also reported the adverse event by phone but no last name or contact details were provided via chat and was unable to verify if this was reported by the same health care professional or not.
Headache; brusing, hematoma, and itching at injection site; brusing, hematoma, and itching at injection site; brusing, hematoma, and itching at injection site; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration, in arm left on 28May2021 11:45 AM (age at the time of vaccination 42-year-old) at a 2nd dose, single dose for COVID-19 immunization. The patient medical history included hypothyroid, allergy to pcn, vancouver, sulfa drugs. The patient concomitant medication included levothyroxine sodium (SYNTHROID) received within 2 weeks of vaccination. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on an unspecified date at a 1st dose, single dose for COVID-19 immunization. The patient did not receive other vaccines prior to the COVID vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested for COVID-19 post vaccination. Since the vaccination, the patient has not been tested for COVID-19. On 29May2021 The patient experienced headache, brusing, hematoma, and itching at injection site after vaccination. The patient did not receive any treatment for the event. No serious criteria reported. Device date is 31May2021. Outcome of the events was recovering.  Information about lot/batch has been requested.
Feeling as if she was going to pass out x 2 days.  Had to actually lie down to avoid passing out.  This is the most worrisome, had minor reaction of muscle aches, and sweating.
Lump in throat 15min after vaccine given, then itching behind ears 45min after shot. Woke up next morning with neck/chest rash, and sensitivity to light and eyes sore with any movement. Diagnosed with optic neuritis.
rash. worst at location site, but also all over body: legs vagina, stomach chest, cheeks, arms
10 minutes after vaccine numbness and tingling in left foot, hand and left side of face.  Spacing out feeling. Feel like i'm going to pass out.
Information has been received from a physician's assistant (PA) concerning a 2-month-old female who on 02-MAR-2007 was vaccinated PO with the first dose of Rotateq. The PA reported that on 06-MAR-2007, the patient developed blood in stool. The patient was seen in the office. In March 2007, 3-5 days after onset, the patient no longer had blood in the stool. Upon internal review, blood in stool was determined to be an other important medical event. Additional information has been requested.
dizziness; Injection site is painful; Injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VACCINATION SITE PAIN (Injection site is painful) and VACCINATION SITE SWELLING (Injection site is swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L02A) for COVID-19 vaccination.     Concomitant products included GABAPENTIN, ALBUTEROL [SALBUTAMOL], HYDRALAZINE, ALPRAZOLAM, CELECOXIB (CELEBREX), INSULIN GLARGINE (LANTUS) and INSULIN ASPART (NOVOLOG) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DIZZINESS (dizziness), VACCINATION SITE PAIN (Injection site is painful) and VACCINATION SITE SWELLING (Injection site is swollen). At the time of the report, DIZZINESS (dizziness), VACCINATION SITE PAIN (Injection site is painful) and VACCINATION SITE SWELLING (Injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.  Vaccination site pain and vaccination site swelling are consistent with the known safety profile of mRNA-1273.
Received vaccine 9 days ago. Developed redness/swelling/tenderness at right upper arm. No fever, no chills. Also complained of tenderness and redness at right axillary lymph node. Right upper arm 5 x 5cm oval, tender erythema surrounding small pox vesicle. Right axillary-small lymph node and enlargement with erythema. Keflex 250 mg po QID, ice, Motrin as needed.
Severe body aches, back ache, head ache that night, the next day had 100.3 fever, chills, severe body aches and backache.
Information has been received from a consumer concerning her 3-year-old son with no pertinent medical history and no drug reactions/allergies who in approximately 2004 was vaccinated SC with a 0.5mL dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy included a probiotic. In approximately 2005 the patient was noted to have developmental problem. "Several tests" were obtained. Unspecified medical attention was sought. The outcome was reported as not recovered. There was no product quality complaint. Additional information has been requested.
Patient presented to receive 2nd dose of Pfizer, did not have vaccine card.  We used a database to verify the apparent 1st dose.  This is when it was discovered that the patient had received Johnson and Johnson in March 2021 and Pfizer from 6/16/2021 (which we did administer).  We did not proceed with another dose.
Seizure; Patient was adminstered DT instead of the DT AP with same day latency; This serious case was reported by a other health professional via other manufacturer and described the occurrence of seizure in a 3-month-old female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included DIPHTHERIA VACCINE TOXOID (DIPHTHERIA TOXOID) for prophylaxis.   On an unknown date, the patient received Pediarix and DIPHTHERIA TOXOID .5 ml. On an unknown date, an unknown time after receiving Pediarix, the patient experienced seizure (Verbatim: Seizure) (serious criteria GSK medically significant and other: serious as per reporter) and overdose (Verbatim: Patient was adminstered DT instead of the DT AP with same day latency). The outcome of the seizure and overdose were unknown.   It was unknown if the reporter considered the seizure to be related to Pediarix and Pediarix Pre-Filled Syringe Device.    It was unknown if the company considered the seizure to be related to Pediarix and Pediarix Pre-Filled Syringe Device.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14-MAR-2023 The reporter stated that Initial information received from an unsolicited valid serious case.  The patient experienced seizure and administering DT instead of the DTAP after receiving vaccines Diphtheria Toxoid and Pediarix.It was unknown if the reporter considered the seizure to be related to DIPHTHERIA VACCINE TOXOID. The patient received Diphtheria Toxoid and Pediarix on same day, which led to overdose of Diphtheria Toxoid.
I had began to have a sore arm and bad body aches at around 9pm. At 2 AM I became delusional and i had a high fever of 104.9. I had a massive headache. The next day I was unable to move my arm at all